|
Delayed
Bombay S.E.
03:02:29 2026-11-17 EST
|
5-day change | 1st Jan Change | ||
| 1,954.35 INR | -0.92% |
|
-3.22% | -7.39% |
| 11-04 | Lupin Limited, Q2 2027 Earnings Call, Nov 04, 2026 | |
| 11-04 | Lupin Launches Generic HIV Drug in U.S. After FDA Approval | MT |
| Market Cap | 902B 9.61B 8.73B 8.06B 7.28B 13.74B 14.23B 96.96B 38.42B 484B 36.04B 35.28B 1,533B | P/E 2027 * |
20.9x | P/E 2028 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 856B 9.11B 8.28B 7.65B 6.91B 13.04B 13.5B 92.01B 36.46B 459B 34.2B 33.48B 1,455B | EV / Sales 2027 * |
2.82x | EV / Sales 2028 * | 2.57x |
| Free-Float |
52.98% | Yield 2027 * |
0.58% | Yield 2028 * | 0.64% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| LUPIN | Delayed | |
| LUPIN | Delayed |
Last Transcript: Lupin Limited
| 1 day | -0.84% | ||
| 1 week | -3.22% | ||
| Current month | -2.64% | ||
| 1 month | +0.11% | ||
| 3 months | -13.43% | ||
| 6 months | -13.19% | ||
| Current year | -7.39% |
| 1 week | 1,954 | 2,029.5 | |
| 1 month | 1,893.25 | 2,061.55 | |
| Current year | 1,893.25 | 2,530 | |
| 1 year | 1,893.25 | 2,530 | |
| 3 years | 1,184 | 2,530 | |
| 5 years | 583.05 | 2,530 | |
| 10 years | 505 | 2,530 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2013-08-31 | |
Brian Savage
PSD | President | 41 | 2026-10-21 |
| Director of Finance/CFO | 61 | 2007-08-12 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 2008-10-07 | |
| Director/Board Member | 58 | 1996-12-31 | |
| Chairman | 83 | 2017-08-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.92% | -3.22% | -4.67% | +63.50% | 9.61B | ||
| -0.82% | +1.40% | +39.64% | +143.17% | 1,275B | ||
| -1.12% | +0.16% | +44.21% | +88.24% | 680B | ||
| -0.16% | +0.43% | +26.76% | +113.01% | 521B | ||
| -0.11% | +2.04% | +43.06% | +72.81% | 389B | ||
| -2.23% | -2.89% | +55.47% | +41.64% | 356B | ||
| -0.54% | +1.72% | +30.01% | +63.11% | 305B | ||
| -0.81% | -0.23% | +3.71% | +38.05% | 287B | ||
| -0.72% | -0.63% | +37.29% | +71.87% | 250B | ||
| -0.30% | -1.03% | +34.04% | +124.88% | 208B | ||
| Average | -0.77% | +0.26% | +30.95% | +82.03% | 428B | |
| Weighted average by Cap. | -0.79% | +0.75% | +36.82% | +97.94% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304B 3.23B 2.94B 2.71B 2.45B 4.63B 4.79B 32.65B 12.94B 163B 12.14B 11.88B 516B | 322B 3.43B 3.12B 2.88B 2.6B 4.91B 5.08B 34.65B 13.73B 173B 12.88B 12.61B 548B |
| Net income | 43.07B 459M 417M 385M 348M 656M 679M 4.63B 1.83B 23.11B 1.72B 1.68B 73.21B | 45.25B 482M 438M 405M 365M 690M 714M 4.86B 1.93B 24.28B 1.81B 1.77B 76.92B |
| Net Debt | -46.06B -491M -446M -412M -372M -702M -727M -4.95B -1.96B -24.72B -1.84B -1.8B -78.29B | -74B -788M -716M -662M -598M -1.13B -1.17B -7.96B -3.15B -39.71B -2.96B -2.89B -126B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-17 | ₹1,954.35 | -0.92% | 209,750 |
| 26-11-16 | ₹1,972.50 | -0.38% | 14,555 |
| 26-11-13 | ₹1,980.00 | -1.69% | 12,670 |
| 26-11-12 | ₹2,014.00 | -0.35% | 144,448 |
| 26-11-11 | ₹2,021.00 | +0.45% | 11,403 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- LUPIN Stock
Select your edition
All financial news and data tailored to specific country editions
















